Work

Epstein–Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor

Year: 2025

Type: article

Source: Nature Microbiology

DOI: 10.1038/s41564-025-02126-0

Authors: Hongbo Wang, Zongjun Mou, Yao Yu Yeo, Qianyun Ge, Xiang Liu, Yohei Narita, Zhixuan Li, Chong Wang, Wanyu Li, Katelyn RS Zhao, Jenny Li, Wei Bu, Benjamin Gewurz, Jeffrey I. Cohen, Mingxiang Teng, Xinghong Dai, Xuefeng Liu, Sizun Jiang, Bo Zhao

Institutions: Brigham and Women's Hospital, Harvard University, Case Western Reserve University, Beth Israel Deaconess Medical Center, The Ohio State University, Moffitt Cancer Center, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases

Awards: Dissecting enhancer function through integrative genomics, Cancer Immune Monitoring and Analysis Center, Targeting Epstein-Barr Virus Super-Enhancer

OpenAlex ID: W4414533723

FWCI: 4.09

Cites: 52

Cited by: 10

Related to: 10